Immunogenicity and Lot-to-Lot Consistency Study of a Quadrivalent Influenza Vaccine in Adult and Elderly Subjects
Phase of Trial: Phase III
Latest Information Update: 24 Apr 2018
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors sanofi pasteur
- 24 Apr 2018 Results of post-hoc subgroup analysis presented at the 28th European Congress of Clinical Microbiology and Infectious Diseases.
- 19 Apr 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database.
- 05 Aug 2014 New trial record